epigallocatechin gallate has been researched along with ginsenoside rg3 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kang, KS; Kim, HY; Yamabe, N; Yokozawa, T | 1 |
| Chen, R; Chung, SK; Hamdoun, S; Ip, CK; Jiang, H; Li, R; Liu, L; Qu, Y; Wong, VKW; Yang, L; Yang, Z; Zhang, D | 1 |
2 other study(ies) available for epigallocatechin gallate and ginsenoside rg3
| Article | Year |
|---|---|
Stereospecificity in hydroxyl radical scavenging activities of four ginsenosides produced by heat processing.
Topics: Free Radical Scavengers; Ginsenosides; Hot Temperature; Hydroxyl Radical; Inhibitory Concentration 50; Stereoisomerism; Structure-Activity Relationship | 2006 |
Identification of natural compounds as SARS-CoV-2 entry inhibitors by molecular docking-based virtual screening with bio-layer interferometry.
Topics: Angiotensin-Converting Enzyme 2; Animals; Antiviral Agents; Binding, Competitive; Biological Products; Catechin; Cell Membrane; Chalcones; Chlorogenic Acid; COVID-19 Drug Treatment; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Enzyme Inhibitors; Ginsenosides; Humans; Interferometry; Mice, Inbred C57BL; Molecular Dynamics Simulation; Phenols; Protein Binding; SARS-CoV-2; Spike Glycoprotein, Coronavirus | 2021 |